CGC
Price
$1.23
Change
+$0.01 (+0.82%)
Updated
Jan 15, 04:59 PM (EDT)
Capitalization
465.25M
22 days until earnings call
Intraday BUY SELL Signals
YCBD
Price
$1.00
Change
-$0.07 (-6.54%)
Updated
Jan 15, 04:59 PM (EDT)
Capitalization
11.23M
Intraday BUY SELL Signals
Interact to see
Advertisement

CGC vs YCBD

Header iconCGC vs YCBD Comparison
Open Charts CGC vs YCBDBanner chart's image
Canopy Growth
Price$1.23
Change+$0.01 (+0.82%)
Volume$185.33K
Capitalization465.25M
CBDMD
Price$1.00
Change-$0.07 (-6.54%)
Volume$7.05K
Capitalization11.23M
CGC vs YCBD Comparison Chart in %
View a ticker or compare two or three
VS
CGC vs. YCBD commentary
Jan 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGC is a Hold and YCBD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 16, 2026
Stock price -- (CGC: $1.22 vs. YCBD: $1.07)
Brand notoriety: CGC: Notable vs. YCBD: Not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CGC: 57% vs. YCBD: 5%
Market capitalization -- CGC: $465.25M vs. YCBD: $11.23M
CGC [@Pharmaceuticals: Generic] is valued at $465.25M. YCBD’s [@Pharmaceuticals: Generic] market capitalization is $11.23M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $65.17B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.59B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGC’s FA Score shows that 0 FA rating(s) are green whileYCBD’s FA Score has 1 green FA rating(s).

  • CGC’s FA Score: 0 green, 5 red.
  • YCBD’s FA Score: 1 green, 4 red.
According to our system of comparison, YCBD is a better buy in the long-term than CGC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGC’s TA Score shows that 4 TA indicator(s) are bullish while YCBD’s TA Score has 5 bullish TA indicator(s).

  • CGC’s TA Score: 4 bullish, 6 bearish.
  • YCBD’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, YCBD is a better buy in the short-term than CGC.

Price Growth

CGC (@Pharmaceuticals: Generic) experienced а +2.52% price change this week, while YCBD (@Pharmaceuticals: Generic) price change was -2.73% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.08%. For the same industry, the average monthly price growth was +6.77%, and the average quarterly price growth was +19.08%.

Reported Earning Dates

CGC is expected to report earnings on Feb 06, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGC($465M) has a higher market cap than YCBD($11.2M). CGC YTD gains are higher at: 7.018 vs. YCBD (-20.741). YCBD has higher annual earnings (EBITDA): 163K vs. CGC (-294.03M). CGC has more cash in the bank: 298M vs. YCBD (1.06M). YCBD has less debt than CGC: YCBD (963K) vs CGC (259M). CGC has higher revenues than YCBD: CGC (279M) vs YCBD (19M).
CGCYCBDCGC / YCBD
Capitalization465M11.2M4,152%
EBITDA-294.03M163K-180,385%
Gain YTD7.018-20.741-34%
P/E RatioN/A2.96-
Revenue279M19M1,468%
Total Cash298M1.06M28,113%
Total Debt259M963K26,895%
FUNDAMENTALS RATINGS
CGC vs YCBD: Fundamental Ratings
CGC
YCBD
OUTLOOK RATING
1..100
1288
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
54
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9899
PRICE GROWTH RATING
1..100
6565
P/E GROWTH RATING
1..100
1001
SEASONALITY SCORE
1..100
8n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

YCBD's Valuation (54) in the Other Consumer Services industry is somewhat better than the same rating for CGC (93) in the Agricultural Commodities Or Milling industry. This means that YCBD’s stock grew somewhat faster than CGC’s over the last 12 months.

YCBD's Profit vs Risk Rating (100) in the Other Consumer Services industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that YCBD’s stock grew similarly to CGC’s over the last 12 months.

CGC's SMR Rating (98) in the Agricultural Commodities Or Milling industry is in the same range as YCBD (99) in the Other Consumer Services industry. This means that CGC’s stock grew similarly to YCBD’s over the last 12 months.

CGC's Price Growth Rating (65) in the Agricultural Commodities Or Milling industry is in the same range as YCBD (65) in the Other Consumer Services industry. This means that CGC’s stock grew similarly to YCBD’s over the last 12 months.

YCBD's P/E Growth Rating (1) in the Other Consumer Services industry is significantly better than the same rating for CGC (100) in the Agricultural Commodities Or Milling industry. This means that YCBD’s stock grew significantly faster than CGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CGCYCBD
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 8 days ago
79%
Bullish Trend about 1 month ago
78%
Declines
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
CGC
Daily Signal:
Gain/Loss:
YCBD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VDMRX10.850.02
+0.18%
Virtus KAR Developing Markets R6
PXIIX22.040.03
+0.14%
Virtus KAR Equity Income I
FOPIX22.34N/A
N/A
Fidelity Advisor Intl Sm Cap Opps I
FRIOX11.93N/A
N/A
Fidelity Advisor Real Estate Income C
AQGRX12.51-0.04
-0.32%
AQR Global Equity R6

CGC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGC has been closely correlated with SNDL. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if CGC jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGC
1D Price
Change %
CGC100%
-2.40%
SNDL - CGC
77%
Closely correlated
-1.21%
ACB - CGC
66%
Closely correlated
+0.47%
CRON - CGC
64%
Loosely correlated
-2.59%
TLRY - CGC
63%
Loosely correlated
+5.43%
OGI - CGC
62%
Loosely correlated
-4.73%
More

YCBD and

Correlation & Price change

A.I.dvisor indicates that over the last year, YCBD has been loosely correlated with TLRY. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if YCBD jumps, then TLRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To YCBD
1D Price
Change %
YCBD100%
+2.88%
TLRY - YCBD
44%
Loosely correlated
+5.43%
ACB - YCBD
43%
Loosely correlated
+0.47%
OGI - YCBD
41%
Loosely correlated
-4.73%
CGC - YCBD
41%
Loosely correlated
-2.40%
CRON - YCBD
33%
Loosely correlated
-2.59%
More